Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report MD Bureau17 Oct 2024 3:13 PM ISTNovavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
COVID-19 vaccine protects people of all body weights from hospitalization and death Isra Zaman2 July 2022 9:30 AM ISTCOVID-19 vaccines greatly reduced the number of cases of severe COVID-19 disease for everyone regardless of their body size, according to a new study...
COVID-19 Vaccines for patients treated for Lung Cancer with Immune checkpoint inhibitors Isra Zaman29 Jun 2022 9:30 AM ISTCancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the...
Top Medical Bulletin 25/June/2022 Dr. Nandita Mohan25 Jun 2022 4:04 PM ISTHere are the top medical stories for today: COVID vaccines safe for patients with cardiovascular disease According to a large study COVID-19...
COVID vaccines safe for patients with pre-existing cardiovascular diseases Dr. Kamal Kant Kohli25 Jun 2022 1:30 PM ISTSophia Antipolis: According to a large study COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with...
COVID vaccines safe for patients with cardiovascular disease Dr. Nandita Mohan25 Jun 2022 9:00 AM ISTAccording to a large study published in Cardiovascular Research, COVID-19 vaccination is not associated with an increased risk of heart attack or...
ICMR releases guidelines for drone use in healthcare MD Bureau3 Jun 2022 11:45 AM ISTThe scientists from ICMR collaborated with the Ministry of Civil Aviation (MoCA), the Government of India, the Directorate General of Civil Aviation...
